Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Tumori ; 107(6): NP127-NP130, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34423702

ABSTRACT

INTRODUCTION: Posttransplant lymphoproliferative disorders (PTLDs) refer to a group of diseases, including diffuse large B-cell lymphoma (DLBCL), that develop after solid organ transplantation or hematopoietic stem cell transplantation. Extranodal involvement in PTLDs is common. Reports about exclusive bone marrow involvement are rare. CASE DESCRIPTION: A 70-year-old woman, who had undergone kidney transplantation in 2018, was diagnosed with exclusively extranodal, Epstein-Barr virus-negative DLBCL, with bone marrow and spleen involvement, during long-term immunosuppression. She achieved complete remission with combined immunochemotherapy and temporary hold of immunosuppression. CONCLUSIONS: This case shows an uncommon clinical presentation of DLBCL, which was challenging to diagnose, being entirely extranodal. The favorable clinical course relied on timely diagnosis and a multidisciplinary approach. Long-term consequences of posttransplant immunosuppression require a high level of suspicion for an appropriate management, aimed at preserving the graft while eradicating the lymphoproliferative disorder.


Subject(s)
Immunosuppressive Agents/adverse effects , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/etiology , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow/pathology , Cyclophosphamide/therapeutic use , Disease Management , Disease Susceptibility , Doxorubicin/therapeutic use , Female , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Immunohistochemistry/methods , Immunosuppressive Agents/therapeutic use , Kidney/pathology , Lymphoma, Large B-Cell, Diffuse/therapy , Organ Transplantation/adverse effects , Positron Emission Tomography Computed Tomography , Prednisone/therapeutic use , Spleen/pathology , Symptom Assessment , Treatment Outcome , Vincristine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...